Glenmark USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials Read more
Leadership evolution in India’s pharmaceutical sector in 2025- Driving global growth and innovation Read more
Sionna Therapeutics’ NBD1 stabilisers hold potential to differentiate from Vertex’s existing therapies in cystic fibrosis: GlobalData Read more
Glenmark announces launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial Read more
Nutraceuticals in preventive healthcare: Regulatory advancements and market growth highlighted at ASSOCHAM Summit Read more